Transparency: Tapping the crowd

Transparency using crowdsourcing, telemedicine for clinical trials; MS is first

Transparency Life Sciences LLC is aiming to run better, cheaper clinical trials by tapping into the collaborative intelligence of stakeholders to design its studies and using telemedicine to capture data and improve enrollment.

While the company ultimately plans to in-license or acquire new compounds, it initially is repurposing generics to see if the approach can work, beginning in multiple sclerosis.

CEO and co-founder Tomasz Sablinski said most clinical trials are designed with the help of a handful of key opinion leaders. Transparency thinks

Read the full 818 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE